Xenetic Biosciences, Inc. Uncategorized Contracts & Agreements
35 Contracts & Agreements
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 21, 2024)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 22, 2023)
- Statement of Work, dated June 30, 2022, between Xenetic Biosciences, Inc. and Catalent Pharma Solutions, LLC (Filed With SEC on August 11, 2022)
- Exclusive Sublicense Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Filed With SEC on August 11, 2022)
- At The Market Offering Agreement by and between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated November 19, 2021 (Filed With SEC on November 19, 2021)
- Form of Letter Agreement by and between Xenetic Biosciences, Inc. and the Holders, dated November 15, 2021 (Filed With SEC on November 16, 2021)
- Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of July 25, 2021 (Filed With SEC on July 28, 2021)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2021)
- Engagement Letter between Xenetic Biosciences, Inc. and H.C. Wainwright & Co., LLC, dated as of December 9, 2020 (Filed With SEC on December 14, 2020)
- Form of Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc (Filed With SEC on March 26, 2020)
- Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for Grigory G. Borisenko, effective as of September 26, 2019 (Filed With SEC on March 26, 2020)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 26, 2020)
- Consent Agreement (Filed With SEC on July 16, 2019)
- CONSENT AGREEMENT (Filed With SEC on June 25, 2019)
- Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for James E. Callaway dated October 11, 2017 (Filed With SEC on March 30, 2018)
- Letter Agreement re. Appointment of Non Employee, Independent Director of Xenetic Biosciences, Inc. for Adam Logal dated October 11, 2017 (Filed With SEC on March 30, 2018)
- Right to Sublicense Agreement, dated October 27, 2017, by and among Xenetic Biosciences, Inc., Baxalta Incorporated, Baxalta US Inc., and Baxalta GmbH (Filed With SEC on March 30, 2018)
- Form of Indemnity Agreement by and between the Registrant and each of its directors and executive officers (Filed With SEC on August 14, 2017)
- Directors Letter Agreement (Filed With SEC on November 22, 2016)
- Directors Letter Agreement (Filed With SEC on July 12, 2016)
- Directors Letter Agreement (Filed With SEC on February 29, 2016)
- FORM OF FIRST AMENDMENT TO SUBSIDIARYGUARANTEE (Filed With SEC on November 16, 2015)
- FORM OF FIRST AMENDMENT TO SECURITYAGREEMENT (Filed With SEC on November 16, 2015)
- FORM OF FIRST AMENDMENT TO REGISTRATION RIGHTSAGREEMENT (Filed With SEC on November 16, 2015)
- ASSIGNMENTAND ASSUMPTION AGREEMENT (Filed With SEC on July 8, 2015)
- Agreement with Mark Leuchtenberger (Filed With SEC on May 6, 2014)
- (1) LIPOXEN PLC (2)LIPOXEN TECHNOLOGIES LTD - and - (2) SERUM INSTITUTE OF INDIA LIMITED ExclusivePatent And Know How Licence and Manufacturing Agreement (Filed With SEC on April 15, 2014)
- 4 August 2011 AGREEMENT ON CO-DEVELOPMENT AND THE TERMS OF EXCLUSIVE LICENCE between (1) LIPOXENPLC (2) LIPOXEN TECHNOLOGIES LTD - and- (3) SYNBIO LLC (Filed With SEC on April 15, 2014)
- AMENDMENT (Filed With SEC on April 15, 2014)
- 200500453-11412 (Filed With SEC on April 15, 2014)
- [***] (Filed With SEC on April 15, 2014)
- The Crown Estate 16 New Burlington Place London W1S2HX TABLE OF CONTENTS (Filed With SEC on April 15, 2014)
- XENETIC BIOSCIENCE, INCORPORATED LEDGEMONT RESEARCH CENTER LEXINGTON, MA (Filed With SEC on April 15, 2014)
- Agreement with Dr. Timothy R. Cot (Filed With SEC on February 10, 2014)
- Order of the High Court of Justice, Chancery Division, entered January 23, 2014 (Filed With SEC on January 29, 2014)
